Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmacology / Federal assistance in the United States / Healthcare reform in the United States / Presidency of Lyndon B. Johnson / Orphan drug / Orphan Drug Act / Patient Protection and Affordable Care Act / Food and Drug Administration / Health / Pharmaceutical sciences / Medicine


Case 1:13-cv[removed]RC Document 1 Filed[removed]Page 1 of 16 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ) PHARMACEUTICAL RESEARCH AND
Add to Reading List

Document Date: 2014-08-05 06:47:44


Open Document

File Size: 66,32 KB

Share Result on Facebook

City

Washington / DC / /

Company

HRSA / Defendant HHS / HHS / Astra USA Inc. / /

Continent

America / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / Judicial Event / Business Partnership / /

Facility

Pharmacy Affairs / /

IndustryTerm

biotechnology / pharmaceutical industry / treat for a rare disease / research-based pharmaceutical / biologic products / healthcare providers / /

MedicalCondition

such disease / rare diseases / disease / free-standing cancer / rare disease / /

Organization

PhRMA / Food and Drug Administration / Gov’t Accountability Office / FDA’s office of Orphan Products Development / Health Resources and Services Administration / Medicare / United States Government / Congress / HRSA office of Pharmacy Affairs / office of Rare Diseases Research / US Federal Reserve / PhRMA’s mission / DEPARTMENT OF HEALTH / office of the Secretary / /

Person

Rockville / MARY K. WAKEFIELD / KATHLEEN SEBELIUS / /

Position

Secretary of Health and Human Services / wholesaler / Secretary / Executive / Administrator / advocate public policies / principal policy advocate / /

Product

Drug / outpatient drug / /

ProgrammingLanguage

DC / /

ProvinceOrState

Maryland / /

Technology

biotechnology / /

URL

http /

SocialTag